Professor Liu has over 30 years of experience in cardiac surgery at Chinese and overseas hospitals. He specializes in the treatment of complex congenital heart disease in newborns and infants. He used to work as a Chief Physician in Cardiac Surgery IPD at Charite Hospital, associated to Humboldt University.

Prof. Huang Lianjun, Deputy CMO of DeltaHealth Hospital, Chief of Medical Imaging and Intervention, professor, Ph.D mentor. He has been awarded 2 National Science and Technology Progress Second prize, 4 Provincial and ministerial awards, and holds 26 national patents. He has published 257 papers and worked as editor-in-Chief of 2 monographs.

He has been engaged in the clinical and scientific research of cardiovascular disease since 1987, and has long been committed to the optimization and technological innovation of coronary artery disease diagnosis and treatment strategies. He has produced a series of achievements in the intravascular ultrasound technology, research and development of new coronary stents, intervention strategies for complex and difficult coronary artery diseases, cell therapy for coronary artery diseases and other fields

Lizhong Sun, M.D., president of DeltaHealth Hospital, professor, chief physician, Ph.D mentor Chief of Cardiac surgery of Capital Medical University. In nearly 40 years of clinical practices in Cardiovascular Surgery, he has independently completed and oversaw junior surgeons in doing more than 25000 cardiovascular surgeries. He is one of the cardiovascular surgeons whotaketheleadin surgical volumes and disease coverage

Weiyi Fang has more than 40 years of experience in the diagnosis and intervention treatment of coronary heart diseases, specializing in intervention treatment of complex coronary disease structured cardiac diseases. Having performed 24,000 cases of coronary intervention, he is one of Chinas pioneering experts in interventional treatment of left main coronary artery disease, chronic total occlusion and complex calcified coronary lesion. He is also among the first experts to perform intervention of structural heart disease, having completed over 700 percutaneous balloon mitral valvuloplasty procedures, as well as over 800 interventional treatments for congenital heart disease.